Bowtech filed a patent infringement lawsuit against Truth Archery on Oct. 2 in Delaware District Court over compound archery bow technology. The suit, brought by Swartz Campbell and Husch Blackwell on ...

CHICAGO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Amplify ETFs, a leading provider of breakthrough ETF solutions, announces filings for the Amplify Stablecoin Technology ETF (QSTB) and Amplify Tokenization ...

Amplify Energy Corp. (NYSE:AMPY) is one of the Cheap Energy Stocks to Buy Under $5. Amplify Energy Corp. (NYSE:AMPY) is up more than 33% since the release of its fiscal second quarter results on ...

This story is jointly published by nonprofits Amplify Utah and The Salt Lake Tribune, to elevate perspectives in local media through student journalism. Ogden • Weber State University’s annual Unity ...

At Amplify Community Resources, the work centers on mental health and wellness. “Our work is based on mental health and wellness,” said founder Ruban Roberts. It has programs like Teen Talk Sessions ...

This story is jointly published by nonprofits Amplify Utah and The Salt Lake Tribune to elevate diverse perspectives in local media through student journalism. Ogden • A steady rain drove a “teach in” ...

Explore Amplify Energy stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AMPY. Mid-cap stocks play an important role in a balanced portfolio, offering a middle ...

AstraZeneca's Calquence has hit the mark in the phase 3 AMPLIFY trial in chronic lymphocytic leukaemia (CLL), a study that chief executive Pascal Soriot recently said could be a "blockbuster ...

Learn everything you need to know about Amplify CEF High Income ETF (YYY) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's the ...

Learn everything you need to know about Amplify Seymour Cannabis ETF (CNBS) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's the ...

SAN FRANCISCO -- In order to maximize weight loss, a GLP-1 receptor agonist may be needed both before and after bariatric surgery, a retrospective analysis found. In 568 patients who underwent ...